Mission Bio CEO and leadership

Charlie Silver is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.

Marcel Roche is a CFO at Mission Bio and is based in San Francisco, California. He has worked as VP Finance & Accounting at ACHAOGEN, INC.; VP Finance & Controller at Guardant Health; and Corporate Controller at Picarro Inc. Marcel studied at Haas School of Business - UC Berkeley and EMLYON Business School.

Mr. Crisitello’s professional career spans the pharmaceutical, biotech, and diagnostic industries. He began his career in pharmaceuticals at Wyeth and the Bristol-Myers Squibb Company, where he held various positions in sales operations, training, marketing, and management. He then moved to multiple start-up organizations where he was responsible for business development and commercialization. Mr. Crisitello became the Senior Director of Hospital Markets at Genoptix Medical Laboratory, where he successfully created a hospital oncology division.

Charlie Silver is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.

Charlie Silver is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.